Completed
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma, +14 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States